For the year ending 2025-12-31, PROF made $16,098K in revenue. -$40,287K in net income. Net profit margin of -250.26%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 16,098 | 10,680 | ||
| Cost of sales | 4,705 | 3,643 | ||
| Gross profit | 11,393 | 7,037 | ||
| Research and development | 20,596 | 16,965 | ||
| Selling, general and administrative | 32,051 | 23,134 | ||
| Total operating expenses | 52,647 | 40,099 | ||
| Operating loss | -41,254 | -33,062 | ||
| Net finance (income) expense | 1,070 | 1,436 | ||
| Net foreign exchange (gain) loss | -2,134 | 3,808 | ||
| Total other (income) expenses | -1,064 | 5,244 | ||
| Net loss before income taxes | -42,318 | -27,818 | ||
| Income tax expense (note 13) | 231 | 144 | ||
| Deferred tax (recovery) expense (note 13) | 21 | -146 | ||
| Total income tax (recovery) expense | 252 | -2 | ||
| Net loss attributed to shareholders for the year | -42,570 | -27,816 | ||
| Foreign currency translation adjustment | 2,283 | -2,823 | ||
| Net loss and other comprehensive loss for the year | -40,287 | -30,639 | ||
| Basic EPS | 1.41 | 1.12 | ||
| Diluted EPS | 1.41 | 1.12 | ||
| Basic Average Shares | 30,232,966 | 24,765,503 | ||
| Diluted Average Shares | 30,232,966 | 24,765,503 | ||
Profound Medical Corp. (PROF)
Profound Medical Corp. (PROF)